News

With the 2026 interim-results season now wrapped up, China's peptide CDMOs have, for the first time, stepped up to the core supply side of global B...

On August 25-27, 2026, CPHI Korea 2026 (World Pharmaceutical Ingredients Korea Exhibition) was grandly opened at the COEX Convention and Exhibition...

CPHI CHINA 2026 · OFFICIAL EXHIBITION FEATURE Suzhou Biosynergy Pharmaceutical Co., Ltd. Invites You to Stand E5D18 A decade of innovation i...

Editor's Note: The 86th Scientific Sessions of the American Diabetes Association (ADA) is being held in New Orleans, USA.

Recently, the Asia-Pacific Economic Cooperation (APEC) meeting was held in Gyeongju, South Korea. Suzhou Biosynergy Pharmaceutical Co., Ltd. (herei...

Recently, the Saigon Exhibition and Convention Center in Ho Chi Minh City, Vietnam, hosted the pharmaceutical industry's annual event –PH...

On the stage of CPHI&PMEC China 2025 in Shanghai, the business vitality surged like a turbulent wave, sweeping through the Shanghai New Interna...

In today's pharmaceutical field, biosimilars are gradually emerging, and their applicable environment has received widespread attention.

The technical requirements for pharmaceutical intermediates mainly include the following aspects:

The trends of the pharmaceutical raw materials industry mainly include the following aspects:

In the global pharmaceutical market, the quality and safety of pharmaceutical products are of vital importance.

Pharmaceutical raw materials can be classified in detail according to different classification standards: